vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and UNITED SECURITY BANCSHARES (UBFO). Click either name above to swap in a different company.
FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $13.5M, roughly 1.0× UNITED SECURITY BANCSHARES). UNITED SECURITY BANCSHARES runs the higher net margin — 25.2% vs -34.7%, a 59.9% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 13.6%). Over the past eight quarters, UNITED SECURITY BANCSHARES's revenue compounded faster (3.0% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
United Security Bancshares is a bank holding company headquartered in Fresno, California. It operates 11 branches.
FENC vs UBFO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $13.5M |
| Net Profit | $-4.8M | $3.4M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 31.5% |
| Net Margin | -34.7% | 25.2% |
| Revenue YoY | 73.8% | 13.6% |
| Net Profit YoY | -141.1% | 36.8% |
| EPS (diluted) | $-0.17 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $13.5M | ||
| Q3 25 | $12.5M | $14.0M | ||
| Q2 25 | $9.7M | $12.6M | ||
| Q1 25 | $8.8M | $13.7M | ||
| Q4 24 | $7.9M | $11.9M | ||
| Q3 24 | $7.0M | $13.8M | ||
| Q2 24 | $7.3M | $13.0M | ||
| Q1 24 | $25.4M | $12.8M |
| Q4 25 | $-4.8M | $3.4M | ||
| Q3 25 | $-638.0K | $4.0M | ||
| Q2 25 | $-3.2M | $2.2M | ||
| Q1 25 | $-1.2M | $2.7M | ||
| Q4 24 | $-2.0M | $2.5M | ||
| Q3 24 | $-5.7M | $3.8M | ||
| Q2 24 | $-5.6M | $4.3M | ||
| Q1 24 | $12.8M | $4.2M |
| Q4 25 | -18.5% | 31.5% | ||
| Q3 25 | -1.5% | 40.3% | ||
| Q2 25 | -28.3% | 24.0% | ||
| Q1 25 | -9.2% | 27.5% | ||
| Q4 24 | -11.8% | 27.5% | ||
| Q3 24 | -74.6% | 37.1% | ||
| Q2 24 | -69.4% | 46.4% | ||
| Q1 24 | 54.2% | 45.9% |
| Q4 25 | -34.7% | 25.2% | ||
| Q3 25 | -5.1% | 28.7% | ||
| Q2 25 | -32.7% | 17.2% | ||
| Q1 25 | -13.3% | 19.6% | ||
| Q4 24 | -25.0% | 20.9% | ||
| Q3 24 | -82.2% | 27.7% | ||
| Q2 24 | -76.5% | 33.0% | ||
| Q1 24 | 50.6% | 32.6% |
| Q4 25 | $-0.17 | $0.18 | ||
| Q3 25 | $-0.02 | $0.23 | ||
| Q2 25 | $-0.11 | $0.13 | ||
| Q1 25 | $-0.04 | $0.16 | ||
| Q4 24 | $-0.02 | $0.14 | ||
| Q3 24 | $-0.21 | $0.22 | ||
| Q2 24 | $-0.20 | $0.25 | ||
| Q1 24 | $0.41 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $264.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $139.7M |
| Total Assets | $70.6M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $264.2M | ||
| Q3 25 | $21.9M | $211.1M | ||
| Q2 25 | $18.7M | $199.5M | ||
| Q1 25 | $22.7M | $198.4M | ||
| Q4 24 | $26.6M | $216.9M | ||
| Q3 24 | $40.3M | $216.8M | ||
| Q2 24 | $43.1M | $166.3M | ||
| Q1 24 | $51.2M | $168.6M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $139.7M | ||
| Q3 25 | $-4.5M | $137.4M | ||
| Q2 25 | $-7.5M | $134.3M | ||
| Q1 25 | $-5.9M | $132.9M | ||
| Q4 24 | $-5.9M | $130.4M | ||
| Q3 24 | $-5.2M | $132.9M | ||
| Q2 24 | $-1.4M | $127.3M | ||
| Q1 24 | $3.0M | $124.2M |
| Q4 25 | $70.6M | $1.2B | ||
| Q3 25 | $49.3M | $1.2B | ||
| Q2 25 | $44.9M | $1.2B | ||
| Q1 25 | $46.4M | $1.2B | ||
| Q4 24 | $44.9M | $1.2B | ||
| Q3 24 | $58.9M | $1.3B | ||
| Q2 24 | $63.2M | $1.2B | ||
| Q1 24 | $69.2M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $22.1M |
| Free Cash FlowOCF − Capex | — | $19.8M |
| FCF MarginFCF / Revenue | — | 146.0% |
| Capex IntensityCapex / Revenue | — | 16.8% |
| Cash ConversionOCF / Net Profit | — | 6.46× |
| TTM Free Cash FlowTrailing 4 quarters | — | $36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $22.1M | ||
| Q3 25 | $1.5M | $7.0M | ||
| Q2 25 | $-3.7M | $8.7M | ||
| Q1 25 | $-4.3M | $3.0M | ||
| Q4 24 | $-1.5M | $19.6M | ||
| Q3 24 | $-2.2M | $5.4M | ||
| Q2 24 | $-8.4M | $2.3M | ||
| Q1 24 | $39.0M | $7.4M |
| Q4 25 | — | $19.8M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $2.9M | ||
| Q4 24 | — | $18.6M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $7.0M |
| Q4 25 | — | 146.0% | ||
| Q3 25 | — | 43.7% | ||
| Q2 25 | — | 64.3% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 156.0% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | 15.5% | ||
| Q1 24 | — | 54.8% |
| Q4 25 | — | 16.8% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 3.6% |
| Q4 25 | — | 6.46× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 4.01× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 7.87× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | 3.04× | 1.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
